OpenVSafe by OpenVAERS
Search V-safe

8GX-16983-16759

1 vaccination 3 coded responses 13 check-ins 3 free-text entries 4 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
908 / CA
Registered
2021-03-18
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-17
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-03-18
    Registered in v-safe
  3. 2021-03-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Migraine with aura — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities
    Free text: Migraine with aura
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-18
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-03-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · Headache, Nausea
    Adult check-in
  6. 2021-03-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Dizzy and lightheaded
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-20
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  8. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2021-03-21
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  11. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  12. 2021-03-24
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · None
    Adult check-in
  13. 2021-04-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-04-10
    Health check-in — day 21, single dose
    Feeling: Good
    Adult check-in
  15. 2021-04-23
    Health check-in — day 35, single dose
    Feeling: Good
    Adult check-in
  16. 2021-04-28
    Health check-in — day 42, single dose
    Feeling: Good
    Adult check-in
  17. 2021-06-16
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  18. 2021-09-17
    Survey response — 6 months, dose 1
    MedDRA: Office visit, Pregnancy, Rash — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Pregnancy related rash · Healthcare visit (other): Regular check up with my OB for my pregnancy
    MedDRA releases: 2024-11 · check-in free text available
  19. 2021-09-17
    Report sent to call center — 6 months, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-09-20

Vaccinations

DoseDateManufacturerCo-administered
12021-03-17Janssen/Johnson & Johnson

Call center

4 call center cases

1 unsuccessful · 3 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-18

Systemic reaction (other): Migraine with aura

Release 6 — days 1–6 daily, dose 1

2021-03-20

Systemic reaction (other): Dizzy and lightheaded

Release 9 — 6 months, dose 1

2021-09-17

Symptoms: Pregnancy related rash
Healthcare visit (other): Regular check up with my OB for my pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOPregnancy · · ✓
SDPregnancy · · ✓
SDRash · · ✓
SRODizziness ✓ ✓ ✓
SROMigraine with aura ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release